Myasthenia Gravis Treatment Market Will Experience Growth, Reaching US$4.1 Billion by the End of 2030, Predicts Persistence Market Research
23 janv. 2024 01h45 HE
|
Persistence Market Research
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Myasthenia Gravis Treatment Market Poised for Steady Growth, driven by Innovation and Rising Awareness The global market for myasthenia gravis (MG)...
Autoimmune Disease Diagnostics Market Surges at 3.8% CAGR from 2019 to 2027 Fueled by Heightened Public Awareness: TMR Report
22 sept. 2023 10h36 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The autoimmune disease diagnostics market was estimated to have acquired US$ 14.4 billion in 2018. It is anticipated to...
Human Microbiome Market Growth Analysis – Reach $2921 Million by 2028 at 22.2% CAGR – Global Report 2021-2028 by The Insight Partners
21 mars 2023 10h28 HE
|
The Insight Partners
New York, March 21, 2023 (GLOBE NEWSWIRE) -- The Insight Partners, “Human Microbiome Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Efgartigimod in Primary Immune Thrombocytopenia
11 nov. 2021 07h30 HE
|
Zai Lab Limited
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), is a patient-focused, innovative, commercial-stage, global...
Nemysis Ltd. Appoints Dr. David S. Sanders to Its Scientific Advisory Board
27 sept. 2021 04h30 HE
|
Nemysis Limited
DUBLIN, Sept. 27, 2021 (GLOBE NEWSWIRE) -- David Sanders, MD, is a professor of Gastroenterology and a Consultant Gastroenterologist at the Royal Hallamshire Hospital & the University of...
InveniAI Announces Successful Completion of Milestone in its Collaboration with PRISM BioLab Focused on Designing Novel Inflammasome-Targeted Therapeutic Candidates
20 juil. 2021 08h10 HE
|
InveniAI LLC
- Successful generation of INVA8003, a peptidomimetic inhibitor of PYCARD (often referred to as ASC, apoptosis-associated speck-like protein containing CARD) triggers milestone payment to PRISM BioLab...
argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China
06 janv. 2021 16h01 HE
|
Zai Lab Limited; argenx
Collaboration to expand and accelerate global development of efgartigimod; expected to allow argenx to more rapidly advance new potential indications into clinical development each yearZai Lab granted...
Trivedi Global, Inc. and Sakina Ansari-Wilson Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical for Decreasing Inflammation and Autoimmune Disorders
28 mai 2019 13h00 HE
|
Trivedi Global, Inc.
Silver Spring, Maryland, USA, May 28, 2019 (GLOBE NEWSWIRE) -- Sakina A. Ansari-Wilson, an evidence-based energy healer, today announces research based on the impact of a biofield energy treated...
Trivedi Global, Inc. in Association with Sakina Ansari-Wilson Announces Research Results on the Impact of a Biofield Energy Treated Nutraceutical to Reduce Inflammation and Autoimmune Disorders
28 mai 2019 12h21 HE
|
Trivedi Global, Inc.
Silver Spring, Maryland, USA, May 28, 2019 (GLOBE NEWSWIRE) -- Sakina A. Ansari-Wilson, an evidence-based healer, today announces research results on the significant impact of a proprietary biofield...
Trivedi Global, Inc. and Maire Mayne Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical to Combat Inflammation and Autoimmune Disorders
13 juil. 2018 09h00 HE
|
Trivedi Global, Inc.
London, United Kingdom, July 13, 2018 (GLOBE NEWSWIRE) -- Maire Mayne, an evidence-based energy healer, today announces research results on the impact of a biofield energy treated nutraceutical to...